Furthermore, through co-cultivation with A549, we directly proved that tumor-infiltrating CD3+ CD+ T cells have a more strong tumor-killing capacity than tumor-infiltrating CD38− CD+ T cells in vitro. Here, CD38 is linked to neoplasm.